CJC-1295 Peptide 2 mg
High-purity peptide designed exclusively for laboratory and scientific research use.
Product Summary
Content: 5 mg lyophilized CJC-1295 peptide
Purity: ≥ 99%
Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
Molecular Weight: ~3367.9 g/mol
Amino Acid Sequence:
Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Gln-Gly-Gly-Cys-Lys
Origin: Synthetic peptide analogue of Growth Hormone Releasing Hormone (GHRH)
Intended Use: Laboratory and research purposes only
What is CJC-1295?
CJC-1295 is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH). It is designed to bind to albumin, extending the half-life of natural GHRH and thereby prolonging GH secretion. Due to its enhanced stability, CJC-1295 has become a significant focus in research related to growth hormone regulation, metabolic health, and healthy aging.
Potential Research Benefits
Prolonged Growth Hormone Release
Provides extended stimulation of GH secretion compared to natural GHRH or shorter-acting analogues.
Increase in IGF-1
Supports sustained elevations in IGF-1 levels, which are important for research on tissue growth and repair.
Muscle and Bone Studies
Investigated in studies involving muscle mass preservation, bone density, and regenerative processes.
Metabolic Health
Potential effects on fat metabolism, insulin sensitivity, and overall energy balance.
Longevity Research
Its role in regulating the GH/IGF-1 axis makes it a valuable tool in aging and regenerative science.
Legal Notice & Disclaimer
For Research Use Only: Not intended for human consumption.
FDA Status: This product has not been evaluated or approved by the U.S. Food and Drug Administration (FDA).
WADA Classification: May be listed as a prohibited substance by the World Anti-Doping Agency (WADA).
Product Details
Packaging: 5 mg lyophilized powder in a sterile glass vial
Storage: Store at 2–8 °C (refrigerated)
Solubility: Soluble in sterile water or bacteriostatic water
After Reconstitution: Recommended for use shortly after reconstitution
Scientific References
Teichman, S.L. et al. (2006). Prolonged stimulation of GH and IGF-I secretion by CJC-1295, a long-acting GHRH analogue, in healthy adults. Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2006-0209
Rahim, A. et al. (1996). Comparison of pharmacokinetics and pharmacodynamics of GHRH and its analogues. Journal of Clinical Endocrinology & Metabolism.
Frohman, L.A. (2009). Regulation of growth hormone synthesis and secretion. Endocrinology and Metabolism Clinics of North America.
Contact & Orders
At TFLL Pharma, we are committed to providing research-grade peptides of the highest purity and quality.
For more information or to place an order for CJC-1295 2 mg, please contact us.
Note: This product is strictly for research purposes. Its use must comply with local regulations and ethical research standards.
